BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,180,030 | +172.4% | 534,712 | +228.8% | 0.07% | +184.0% |
| Q2 2023 | $7,409,377 | +34.8% | 162,629 | +20.0% | 0.02% | +31.6% |
| Q1 2023 | $5,497,989 | -19.9% | 135,552 | +0.7% | 0.02% | -24.0% |
| Q4 2022 | $6,864,028 | -15.7% | 134,668 | -10.9% | 0.02% | +56.2% |
| Q3 2022 | $8,142,600 | -50.8% | 151,192 | -41.3% | 0.02% | -48.4% |
| Q2 2022 | $16,547,852 | -55.8% | 257,632 | -46.7% | 0.03% | -41.5% |
| Q1 2022 | $37,447,894 | +96.2% | 482,948 | +117.2% | 0.05% | +8.2% |
| Q4 2021 | $19,084,000 | -30.3% | 222,315 | -34.7% | 0.05% | -36.4% |
| Q3 2021 | $27,383,000 | +266.4% | 340,462 | +266.7% | 0.08% | +600.0% |
| Q2 2021 | $7,474,000 | +1058.8% | 92,834 | +1115.1% | 0.01% | +450.0% |
| Q1 2021 | $645,000 | +2.5% | 7,640 | -2.5% | 0.00% | 0.0% |
| Q4 2020 | $629,000 | -89.2% | 7,838 | -89.1% | 0.00% | -90.5% |
| Q3 2020 | $5,807,000 | -86.4% | 72,198 | -85.5% | 0.02% | -75.0% |
| Q2 2020 | $42,834,000 | -0.4% | 497,494 | -6.1% | 0.08% | -22.2% |
| Q1 2020 | $43,004,000 | +8.1% | 529,666 | +11.3% | 0.11% | +33.3% |
| Q4 2019 | $39,778,000 | -14.9% | 475,690 | -11.0% | 0.08% | -12.9% |
| Q3 2019 | $46,746,000 | +6.4% | 534,438 | -0.4% | 0.09% | +8.1% |
| Q2 2019 | $43,938,000 | +106.3% | 536,500 | +104.8% | 0.09% | +3.6% |
| Q1 2019 | $21,300,000 | +31.0% | 261,958 | +6.0% | 0.08% | +16.9% |
| Q4 2018 | $16,262,000 | -47.0% | 247,054 | -37.9% | 0.07% | -36.6% |
| Q3 2018 | $30,671,000 | +66.8% | 397,855 | +59.7% | 0.11% | +60.0% |
| Q2 2018 | $18,390,000 | +15.8% | 249,055 | +2.0% | 0.07% | +11.1% |
| Q1 2018 | $15,878,000 | -16.4% | 244,120 | -16.9% | 0.06% | -16.0% |
| Q4 2017 | $18,987,000 | -5.2% | 293,728 | -7.9% | 0.08% | -12.8% |
| Q3 2017 | $20,020,000 | +4.7% | 319,039 | +1.0% | 0.09% | -1.1% |
| Q2 2017 | $19,127,000 | -69.5% | 315,939 | -73.8% | 0.09% | -69.3% |
| Q1 2017 | $62,613,000 | +431.1% | 1,207,342 | +354.1% | 0.28% | +414.5% |
| Q4 2016 | $11,789,000 | +4.3% | 265,866 | +11.9% | 0.06% | +10.0% |
| Q3 2016 | $11,308,000 | +46.7% | 237,566 | +39.4% | 0.05% | +47.1% |
| Q2 2016 | $7,706,000 | +2.0% | 170,406 | -7.3% | 0.03% | 0.0% |
| Q1 2016 | $7,555,000 | -27.6% | 183,902 | -32.7% | 0.03% | -26.1% |
| Q4 2015 | $10,428,000 | -37.9% | 273,363 | -46.5% | 0.05% | -33.3% |
| Q3 2015 | $16,791,000 | -92.0% | 511,139 | -83.1% | 0.07% | -91.8% |
| Q2 2015 | $211,139,000 | +13.7% | 3,019,281 | +11.4% | 0.84% | +10.5% |
| Q1 2015 | $185,731,000 | -3.3% | 2,711,405 | +3.5% | 0.76% | -0.6% |
| Q4 2014 | $191,974,000 | +134.4% | 2,619,371 | +129.5% | 0.77% | +120.0% |
| Q3 2014 | $81,913,000 | +58.7% | 1,141,339 | +59.9% | 0.35% | +62.8% |
| Q2 2014 | $51,621,000 | +27.5% | 713,973 | +29.8% | 0.22% | +22.2% |
| Q1 2014 | $40,478,000 | +66.2% | 550,121 | +57.1% | 0.18% | +61.5% |
| Q4 2013 | $24,362,000 | +10.9% | 350,278 | +4.7% | 0.11% | +0.9% |
| Q3 2013 | $21,977,000 | +2.2% | 334,552 | +7.8% | 0.11% | -5.3% |
| Q2 2013 | $21,497,000 | – | 310,334 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |